EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Measurement of Complement Activation via Plasma-Soluble C5b-9 Comparison with Terminal Complement Complex Staining in a Series of Kidney Biopsies

Carolyn Wijaya, Christine Burns, Sharron Hall, Melissa Farmer, Denise Jones, Matthew Rowlandson, Peter Choi, Mark Formby, Theo de Malmanche

Kidney and Blood Pressure Research · 2023

DOI: 10.1159/000529734 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney and Blood Pressure Research, 2023. Verfasst von Carolyn Wijaya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunopathology, NSW Health Pathology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia. Hauptthemen laut MEDLINE: Complement Membrane Attack Complex, Kidney Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

With the emergence of therapeutic complement inhibitors, there is a need to identify patients with complement-driven inflammation. C5b-9 is the terminal product of the three complement pathways and therefore a marker of total complement activation. We present a pilot study which aims to assess whether plasma soluble C5b-9 (sC5b-9) correlates with terminal complement complex (TCC) staining in kidney tissue. The secondary aim was to assess the utility of plasma sC5b-9 as part of routine workup in kidney patients undergoing kidney biopsy.

Methods

Thirty-seven patients undergoing kidney biopsy had plasma sC5b-9 and TCC staining on kidney tissue performed. Additional blood markers including creatinine, haemoglobin, CRP, factor H, factor I, and midkine levels were also taken. These parameters were correlated with the histological diagnoses. Patients were divided into a diseased group (n = 31) and a control group (n = 6) consisting of transplanted kidneys with minor or no changes. Of the biopsies in the control group, 50% were performed as per protocol, and the other 50% were performed due to clinical need.

Results

There was no correlation found between plasma sC5b-9 and TCC kidney staining. Elevated sC5b-9 levels were found in a heterogeneous group of patients but were associated with higher CRP and lower haemoglobin levels. Overall, there was more TCC kidney staining in the diseased group compared with the control group, and a trend was observed of diabetic, primary membranous nephropathy, and amyloidosis patients having more intense glomerular and peritubular/interstitial staining.

Conclusion

Plasma sC5b-9 as a marker of total complement activation does not correlate with TCC kidney staining. This discordance suggests that plasma sC5b-9 and TCC staining are distinct markers of disease. TCC staining reflects chronicity and tissue deposition of complement over time. Conversely, plasma sC5b-9 concentrations change rapidly and reflect systemic complement activation. Complement activation was present in a heterogeneous group of kidney disease, indicating the underlying role of complement in many disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement Membrane Attack ComplexKidney DiseasesHumansPilot ProjectsComplement System ProteinsComplement ActivationKidneyBiopsyHemoglobins

Stichwörter der Autor:innen

C5b-9ComplementComplement activationKidney biopsySoluble C5b-9Terminal complement complex

Substanzen

Complement Membrane Attack ComplexComplement System ProteinsHemoglobins

Autor:innen und Institutionen

  • Immunopathology, NSW Health Pathology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
  • University of Newcastle, University Drive, Callaghan, New South Wales, Australia.
  • Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.
  • Anatomical Pathology, NSW Health Pathology, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
  • Renal Department, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.

Zitieren

APA

Wijaya, C., Burns, C., Hall, S., Farmer, M., Jones, D., Rowlandson, M., Choi, P., Formby, M., & de Malmanche, T. (2023). Measurement of Complement Activation via Plasma-Soluble C5b-9 Comparison with Terminal Complement Complex Staining in a Series of Kidney Biopsies. Kidney and Blood Pressure Research. https://doi.org/10.1159/000529734

Vancouver

Wijaya C, Burns C, Hall S, Farmer M, Jones D, Rowlandson M, et al. Measurement of Complement Activation via Plasma-Soluble C5b-9 Comparison with Terminal Complement Complex Staining in a Series of Kidney Biopsies. Kidney and Blood Pressure Research. 2023. doi:10.1159/000529734

BibTeX
@article{Wijaya2023,
  author = {Wijaya, Carolyn and Burns, Christine and Hall, Sharron and Farmer, Melissa and Jones, Denise and Rowlandson, Matthew and Choi, Peter and Formby, Mark and de Malmanche, Theo},
  title = {Measurement of Complement Activation via Plasma-Soluble C5b-9 Comparison with Terminal Complement Complex Staining in a Series of Kidney Biopsies},
  journal = {Kidney and Blood Pressure Research},
  year = {2023},
  doi = {10.1159/000529734}
}
Kostenlos starten →